Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: E9B5F0
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 28 | 30 | PF00675 | 0.401 |
CLV_NRD_NRD_1 | 53 | 55 | PF00675 | 0.328 |
CLV_NRD_NRD_1 | 69 | 71 | PF00675 | 0.328 |
CLV_PCSK_KEX2_1 | 28 | 30 | PF00082 | 0.401 |
CLV_PCSK_KEX2_1 | 53 | 55 | PF00082 | 0.401 |
CLV_PCSK_SKI1_1 | 32 | 36 | PF00082 | 0.354 |
CLV_PCSK_SKI1_1 | 53 | 57 | PF00082 | 0.336 |
DEG_Nend_UBRbox_4 | 1 | 3 | PF02207 | 0.645 |
DOC_PP2B_PxIxI_1 | 120 | 126 | PF00149 | 0.712 |
DOC_PP4_FxxP_1 | 35 | 38 | PF00568 | 0.344 |
DOC_USP7_MATH_1 | 127 | 131 | PF00917 | 0.725 |
DOC_USP7_MATH_1 | 38 | 42 | PF00917 | 0.444 |
DOC_USP7_MATH_1 | 4 | 8 | PF00917 | 0.392 |
LIG_14-3-3_CanoR_1 | 32 | 38 | PF00244 | 0.477 |
LIG_Actin_WH2_2 | 17 | 34 | PF00022 | 0.284 |
LIG_Actin_WH2_2 | 58 | 75 | PF00022 | 0.401 |
LIG_BRCT_BRCA1_1 | 142 | 146 | PF00533 | 0.766 |
LIG_FHA_1 | 50 | 56 | PF00498 | 0.401 |
LIG_FHA_2 | 162 | 168 | PF00498 | 0.691 |
LIG_IBAR_NPY_1 | 17 | 19 | PF08397 | 0.310 |
LIG_LIR_Gen_1 | 112 | 123 | PF02991 | 0.585 |
LIG_MLH1_MIPbox_1 | 142 | 146 | PF16413 | 0.766 |
LIG_PDZ_Class_1 | 168 | 173 | PF00595 | 0.553 |
LIG_Pex14_2 | 35 | 39 | PF04695 | 0.344 |
LIG_SH2_CRK | 85 | 89 | PF00017 | 0.470 |
LIG_SH2_NCK_1 | 85 | 89 | PF00017 | 0.587 |
LIG_SH2_SRC | 110 | 113 | PF00017 | 0.560 |
LIG_SH2_STAP1 | 107 | 111 | PF00017 | 0.552 |
LIG_SH2_STAP1 | 115 | 119 | PF00017 | 0.626 |
LIG_SH2_STAP1 | 162 | 166 | PF00017 | 0.749 |
LIG_SH2_STAP1 | 79 | 83 | PF00017 | 0.529 |
LIG_SH2_STAT3 | 19 | 22 | PF00017 | 0.525 |
LIG_SH2_STAT5 | 110 | 113 | PF00017 | 0.634 |
LIG_SH2_STAT5 | 145 | 148 | PF00017 | 0.693 |
LIG_SH2_STAT5 | 47 | 50 | PF00017 | 0.344 |
LIG_TRAF2_1 | 99 | 102 | PF00917 | 0.618 |
LIG_UBA3_1 | 135 | 141 | PF00899 | 0.717 |
MOD_CK2_1 | 161 | 167 | PF00069 | 0.671 |
MOD_CK2_1 | 4 | 10 | PF00069 | 0.657 |
MOD_CK2_1 | 96 | 102 | PF00069 | 0.654 |
MOD_GlcNHglycan | 102 | 105 | PF01048 | 0.601 |
MOD_GlcNHglycan | 112 | 115 | PF01048 | 0.622 |
MOD_GlcNHglycan | 128 | 132 | PF01048 | 0.594 |
MOD_GSK3_1 | 96 | 103 | PF00069 | 0.652 |
MOD_NEK2_1 | 49 | 54 | PF00069 | 0.366 |
MOD_NEK2_1 | 96 | 101 | PF00069 | 0.601 |
MOD_NEK2_2 | 4 | 9 | PF00069 | 0.599 |
MOD_PIKK_1 | 140 | 146 | PF00454 | 0.758 |
MOD_Plk_4 | 22 | 28 | PF00069 | 0.354 |
MOD_SUMO_rev_2 | 64 | 72 | PF00179 | 0.444 |
TRG_ENDOCYTIC_2 | 115 | 118 | PF00928 | 0.616 |
TRG_ER_diArg_1 | 27 | 29 | PF00400 | 0.401 |
TRG_ER_diArg_1 | 53 | 55 | PF00400 | 0.401 |
TRG_NES_CRM1_1 | 66 | 80 | PF08389 | 0.444 |
TRG_Pf-PMV_PEXEL_1 | 53 | 58 | PF00026 | 0.344 |
TRG_Pf-PMV_PEXEL_1 | 60 | 64 | PF00026 | 0.344 |
TRG_Pf-PMV_PEXEL_1 | 70 | 74 | PF00026 | 0.291 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HT17 | Leptomonas seymouri | 78% | 100% |
A0A0S4JIG2 | Bodo saltans | 49% | 100% |
A0A1X0PAC2 | Trypanosomatidae | 66% | 100% |
A0A3S7X8B7 | Leishmania donovani | 92% | 100% |
A4HB79 | Leishmania braziliensis | 89% | 100% |
A4IAC7 | Leishmania infantum | 92% | 100% |
C9ZLW6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 64% | 100% |
Q4Q2I3 | Leishmania major | 92% | 100% |